Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Boss G. R., Seegmiller J. E. Hyperuricemia and gout. Classification, complications and management. N Engl J Med. 1979 Jun 28;300(26):1459–1468. doi: 10.1056/NEJM197906283002604. [DOI] [PubMed] [Google Scholar]
- Dan M., Jedwab M., Peled M., Shibolet S. Allopurinol-induced toxic epidermal necrolysis. Int J Dermatol. 1984 Mar;23(2):142–144. doi: 10.1111/j.1365-4362.1984.tb05689.x. [DOI] [PubMed] [Google Scholar]
- Duffy W. B., Senekjian H. O., Knight T. F., Weinman E. J. Management of asymptomatic hyperuricemia. JAMA. 1981 Nov 13;246(19):2215–2216. [PubMed] [Google Scholar]
- Ellman M. H., Fretzin D. F., Olson W. Toxic epidermal necrolysis associated with allopurinol administration. Arch Dermatol. 1975 Aug;111(8):986–990. [PubMed] [Google Scholar]
- Emmerson B. T. Hyperuricaemia--to treat or not? Drugs. 1975;9(2):141–152. doi: 10.2165/00003495-197509020-00003. [DOI] [PubMed] [Google Scholar]
- Hande K. R., Noone R. M., Stone W. J. Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency. Am J Med. 1984 Jan;76(1):47–56. doi: 10.1016/0002-9343(84)90743-5. [DOI] [PubMed] [Google Scholar]
- Kantor G. L. Toxic epidermal necrolysis, azotemia, and death after allopurinol therapy. JAMA. 1970 Apr 20;212(3):478–479. [PubMed] [Google Scholar]
- Liang M. H., Fries J. F. Asymptomatic hyperuricemia: the case for conservative management. Ann Intern Med. 1978 May;88(5):666–670. doi: 10.7326/0003-4819-88-5-666. [DOI] [PubMed] [Google Scholar]
- Lupton G. P., Odom R. B. The allopurinol hypersensitivity syndrome. J Am Acad Dermatol. 1979 Oct;1(4):365–374. doi: 10.1016/s0190-9622(79)70031-4. [DOI] [PubMed] [Google Scholar]
- Lyell A. Toxic epidermal necrolysis (the scalded skin syndrome): a reappraisal. Br J Dermatol. 1979 Jan;100(1):69–86. doi: 10.1111/j.1365-2133.1979.tb03571.x. [DOI] [PubMed] [Google Scholar]
- McInnes G. T., Lawson D. H., Jick H. Acute adverse reactions attributed to allopurinol in hospitalised patients. Ann Rheum Dis. 1981 Jun;40(3):245–249. doi: 10.1136/ard.40.3.245. [DOI] [PMC free article] [PubMed] [Google Scholar]